激动剂-话题@MedSci

#激动剂#

173篇内容 | 3329人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1627766, encodeId=b76d162e766a4, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=GLP-1受体激动剂临床应用专家指导意见, objectType=article, longId=142197, objectId=3f2414219e1b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f2414219e1b, replyNumber=0, likeNumber=29, createdTime=2018-07-03, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f2414219e1b, moduleTitle=GLP-1受体激动剂临床应用专家指导意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f2414219e1b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627765, encodeId=ac8b162e76523, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=JACC：CD31激动剂有望改善急性主动脉夹层预后, objectType=article, longId=141949, objectId=9ea7141949cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ea7141949cb, replyNumber=0, likeNumber=69, createdTime=2018-07-01, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ea7141949cb, moduleTitle=JACC：CD31激动剂有望改善急性主动脉夹层预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ea7141949cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627764, encodeId=f179162e76493, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Lancet：GLP-1及胰高血糖素受体双重激动剂MEDI0382可改善II型糖尿病患者体重, objectType=article, longId=141602, objectId=62b1141602a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62b1141602a2, replyNumber=0, likeNumber=67, createdTime=2018-06-27, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62b1141602a2, moduleTitle=Lancet：GLP-1及胰高血糖素受体双重激动剂MEDI0382可改善II型糖尿病患者体重, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62b1141602a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627763, encodeId=bd79162e76343, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简, objectType=article, longId=138587, objectId=655813858e8c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=655813858e8c, replyNumber=0, likeNumber=34, createdTime=2018-05-20, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=655813858e8c, moduleTitle=2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=655813858e8c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627762, encodeId=12d5162e76275, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Circ Res：生长激素释放激素及其激动剂对血管钙化的调节作用, objectType=article, longId=134992, objectId=143313499215, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=143313499215, replyNumber=0, likeNumber=47, createdTime=2018-04-13, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=143313499215, moduleTitle=Circ Res：生长激素释放激素及其激动剂对血管钙化的调节作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=143313499215)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627761, encodeId=1ca7162e761c6, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Lancet oncol：ALT-803（IL-15强激动剂）联合nivolumab用于转移性非小细胞肺癌安全性可耐受, objectType=article, longId=134404, objectId=edd7134404aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edd7134404aa, replyNumber=0, likeNumber=38, createdTime=2018-04-08, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edd7134404aa, moduleTitle=Lancet oncol：ALT-803（IL-15强激动剂）联合nivolumab用于转移性非小细胞肺癌安全性可耐受, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edd7134404aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627760, encodeId=d490162e76075, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Lancet Diabetes Endo：GLP-1受体激动剂是否有心血管保护作用？, objectType=article, longId=131617, objectId=7fb513161eba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fb513161eba, replyNumber=0, likeNumber=108, createdTime=2018-03-08, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fb513161eba, moduleTitle=Lancet Diabetes Endo：GLP-1受体激动剂是否有心血管保护作用？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fb513161eba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627759, encodeId=6a34162e759c8, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=J Indian Soc Periodontol：吸烟者中核因子κB-β受体激动剂与临床附着水平的关系, objectType=article, longId=131337, objectId=172213133e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=172213133e98, replyNumber=0, likeNumber=50, createdTime=2018-03-05, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=172213133e98, moduleTitle=J Indian Soc Periodontol：吸烟者中核因子κB-β受体激动剂与临床附着水平的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=172213133e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627758, encodeId=2850162e758fe, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=JAMA Intern Med：COPD患者新接受长效β2激动剂或长效M拮抗剂导致心血管疾病风险增加, objectType=article, longId=125387, objectId=a18112538e0b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a18112538e0b, replyNumber=0, likeNumber=56, createdTime=2018-01-05, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a18112538e0b, moduleTitle=JAMA Intern Med：COPD患者新接受长效β2激动剂或长效M拮抗剂导致心血管疾病风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a18112538e0b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627757, encodeId=65b3162e75756, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Int. J. Pharm：一种新型口服给药生长素释放肽激动剂多肽缓释胶囊：制剂设计和体外表征, objectType=article, longId=124931, objectId=fe1e124931a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe1e124931a8, replyNumber=0, likeNumber=77, createdTime=2017-12-30, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe1e124931a8, moduleTitle=Int. J. Pharm：一种新型口服给药生长素释放肽激动剂多肽缓释胶囊：制剂设计和体外表征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe1e124931a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627756, encodeId=3bfb162e7564e, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Chest：探索苯二氮䓬类受体激动剂和肺炎住院风险之间的相关性, objectType=article, longId=124705, objectId=a4fd124e05da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4fd124e05da, replyNumber=0, likeNumber=61, createdTime=2017-12-28, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4fd124e05da, moduleTitle=Chest：探索苯二氮䓬类受体激动剂和肺炎住院风险之间的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4fd124e05da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627755, encodeId=a5bc162e75542, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病, objectType=article, longId=124605, objectId=82221246057a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82221246057a, replyNumber=0, likeNumber=29, createdTime=2017-12-27, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82221246057a, moduleTitle=2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82221246057a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627754, encodeId=8eea162e75485, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Hepatology：GLP-1受体激动剂改善脂肪肝时肝脏内质网应激新机制, objectType=article, longId=124117, objectId=11df12411e88, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11df12411e88, replyNumber=0, likeNumber=70, createdTime=2017-12-22, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11df12411e88, moduleTitle=Hepatology：GLP-1受体激动剂改善脂肪肝时肝脏内质网应激新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11df12411e88)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627753, encodeId=f5ce162e75310, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Diabetes care：GLP-1受体激动剂在控制欠佳2型糖尿病中的功效和安全性！, objectType=article, longId=123879, objectId=9be81238e985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9be81238e985, replyNumber=0, likeNumber=58, createdTime=2017-12-20, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9be81238e985, moduleTitle=Diabetes care：GLP-1受体激动剂在控制欠佳2型糖尿病中的功效和安全性！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9be81238e985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627752, encodeId=bb54162e75211, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=CLIN CANCER RES：4-1BB激动剂增强胰腺癌CD8+肿瘤浸润淋巴细胞功能, objectType=article, longId=122638, objectId=17eb122638a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17eb122638a6, replyNumber=0, likeNumber=72, createdTime=2017-12-09, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17eb122638a6, moduleTitle=CLIN CANCER RES：4-1BB激动剂增强胰腺癌CD8+肿瘤浸润淋巴细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17eb122638a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627751, encodeId=43a9162e75150, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Sci Rep：研究揭示人牙周膜干细胞对IFN-γ和TLR激动剂的反应, objectType=article, longId=117185, objectId=813e11e185f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=813e11e185f4, replyNumber=0, likeNumber=54, createdTime=2017-10-24, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=813e11e185f4, moduleTitle=Sci Rep：研究揭示人牙周膜干细胞对IFN-γ和TLR激动剂的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=813e11e185f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627750, encodeId=6ae7162e75076, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局, objectType=article, longId=115971, objectId=da471159e1cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da471159e1cb, replyNumber=0, likeNumber=59, createdTime=2017-10-14, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da471159e1cb, moduleTitle=Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da471159e1cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627749, encodeId=0947162e749a6, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Front Pharmacol：腺苷受体激动剂可有效预防和治疗骨质疏松症, objectType=article, longId=115183, objectId=2435115183a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2435115183a0, replyNumber=0, likeNumber=67, createdTime=2017-10-05, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2435115183a0, moduleTitle=Front Pharmacol：腺苷受体激动剂可有效预防和治疗骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2435115183a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627748, encodeId=7527162e74841, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=JCEM：家族性高钙血症患者接受钙受体激动剂治疗的安全性和有效性研究, objectType=article, longId=114581, objectId=92f8114581e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92f8114581e7, replyNumber=0, likeNumber=59, createdTime=2017-09-29, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92f8114581e7, moduleTitle=JCEM：家族性高钙血症患者接受钙受体激动剂治疗的安全性和有效性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92f8114581e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627747, encodeId=ca6c162e747b6, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=ANN ONCOL：GnRH激动剂可以减轻乳腺癌化疗卵巢毒性, objectType=article, longId=111359, objectId=84ae1113590e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ae1113590e, replyNumber=0, likeNumber=50, createdTime=2017-09-01, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ae1113590e, moduleTitle=ANN ONCOL：GnRH激动剂可以减轻乳腺癌化疗卵巢毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84ae1113590e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

激动剂

2020-05-29

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

GLP-1受体激动剂临床应用专家指导意见

2018-07-03

柳叶一刀 (审核中...)

前往app查看评论内容

#激动剂#

JACC：CD31激动剂有望改善急性主动脉夹层预后

2018-07-01

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Lancet：GLP-1及胰高血糖素受体双重激动剂MEDI0382可改善II型糖尿病患者体重

2018-06-27

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

2018 CFPC循证临床实践指南：苯二氮䓬类受体激动剂处方精简

2018-05-20

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Circ Res：生长激素释放激素及其激动剂对血管钙化的调节作用

2018-04-13

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Lancet oncol：ALT-803（IL-15强激动剂）联合nivolumab用于转移性非小细胞肺癌安全性可耐受

2018-04-08

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Lancet Diabetes Endo：GLP-1受体激动剂是否有心血管保护作用？

2018-03-08

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

J Indian Soc Periodontol：吸烟者中核因子κB-β受体激动剂与临床附着水平的关系

2018-03-05

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

JAMA Intern Med：COPD患者新接受长效β2激动剂或长效M拮抗剂导致心血管疾病风险增加

2018-01-05

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Int. J. Pharm：一种新型口服给药生长素释放肽激动剂多肽缓释胶囊：制剂设计和体外表征

2017-12-30

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Chest：探索苯二氮䓬类受体激动剂和肺炎住院风险之间的相关性

2017-12-28

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

2017 KDA立场声明：胰高血糖素样肽-1受体激动剂治疗2型糖尿病

2017-12-27

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Hepatology：GLP-1受体激动剂改善脂肪肝时肝脏内质网应激新机制

2017-12-22

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Diabetes care：GLP-1受体激动剂在控制欠佳2型糖尿病中的功效和安全性！

2017-12-20

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

CLIN CANCER RES：4-1BB激动剂增强胰腺癌CD8+肿瘤浸润淋巴细胞功能

2017-12-09

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Sci Rep：研究揭示人牙周膜干细胞对IFN-γ和TLR激动剂的反应

2017-10-24

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Circulation：GLP-1受体激动剂和DPP-4抑制剂的心血管作用和临床结局

2017-10-14

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Front Pharmacol：腺苷受体激动剂可有效预防和治疗骨质疏松症

2017-10-05

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

JCEM：家族性高钙血症患者接受钙受体激动剂治疗的安全性和有效性研究

2017-09-29

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

ANN ONCOL：GnRH激动剂可以减轻乳腺癌化疗卵巢毒性

2017-09-01

科室
- - 订阅+
  - 更多科室
工具
服务